Is the active ingredient in this medication.
Dactinomycin is a chemotherapy drug primarily used to treat various types of cancers, including:
Wilms tumor (a type of kidney cancer in children)
Rhabdomyosarcoma (a type of soft tissue cancer)
Ewing's sarcoma (a type of bone cancer)
Certain types of leukemia
Other solid tumors.
Resdac 0.5mg Injection (Dactinomycin) works by interfering with the DNA replication process within cancer cells. It binds to DNA, preventing the cells from dividing and growing, ultimately leading to their death.
Store dactinomycin at room temperature, away from direct sunlight and moisture.
Keep it out of reach of children and pets.
Do not flush unused medication down the toilet or pour it into a drain.
Dispose of the medication properly as directed by your healthcare provider or local pharmacy.
The dosage of dactinomycin is determined by your healthcare provider based on your individual needs and medical condition.
It is typically administered intravenously (into a vein) by a healthcare professional.
The frequency and duration of treatment may vary depending on the type of cancer being treated.
Dactinomycin can cause various side effects, some of which may be severe.
Common side effects include:
Severe side effects may include:
Nausea and vomiting
Loss of appetite
Hair loss
Mouth sores
Diarrhea
Fatigue
Skin discoloration
Low blood cell counts (including red blood cells, white blood cells, and platelets).
Heart problems
Lung damage
Liver damage
Kidney damage
Secondary cancers (in rare cases).
It is advisable to avoid alcohol consumption while taking dactinomycin, as it can worsen potential side effects, particularly liver damage.
Dactinomycin can cause fatigue and other side effects that may impair your ability to drive or operate machinery. It is essential to exercise caution and avoid these activities if you experience any such side effects.
Dactinomycin is a highly teratogenic drug (can cause birth defects) and is contraindicated in pregnancy. It is also not recommended for breastfeeding mothers as it can be passed to the baby through breast milk.
Dactinomycin is a potent drug and should only be used in children under the strict supervision of a healthcare provider.
Patients with pre-existing kidney or liver problems may need to have their dosage adjusted or undergo close monitoring while receiving dactinomycin.
National Cancer Institute (NCI): https://www.cancer.gov/
Drugs.com: https://www.drugs.com/
Mayo Clinic: https://www.mayoclinic.org/
Your doctor's instructions and patient information leaflet.
